{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:01:56Z","timestamp":1792598516143,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National key Research and Development Program","doi-asserted-by":"crossref","award":["2021YFC2401204"],"award-info":[{"award-number":["2021YFC2401204"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301643"],"award-info":[{"award-number":["82301643"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M732470"],"award-info":[{"award-number":["2023M732470"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC1641"],"award-info":[{"award-number":["2025ZNSFSC1641"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC1577"],"award-info":[{"award-number":["2024NSFSC1577"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Post-Doctor Research Project, West China Hospital, Sichuan University","award":["2023HXBH101"],"award-info":[{"award-number":["2023HXBH101"]}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2023YFQ0109"],"award-info":[{"award-number":["2023YFQ0109"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Epileptologica"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vagus nerve stimulation (VNS) has been widely used in the clinical treatment of epilepsy, while its effects on comorbidities in epilepsy remain incompletely elucidated. This study aimed to evaluate the impact of VNS on comorbidities and quality of life in adult patients with epilepsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A longitudinal, multicenter cohort study was conducted from 2021 to 2024 among adult patients with epilepsy who underwent VNS implantation. We enrolled 128 participants from 83 hospitals. The inclusion criteria were patients over 18\u00a0years old, diagnosed with epilepsy according to the 2014 International League Against Epilepsy guidelines, and having complete data from at least two follow-up visits. Standard assessment tools, including diagnosis according to International Classification of Diseases, 10th Edition (ICD-10), Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), Generalized Anxiexy Disorde-7 (GAD-7), Pittsburgh Sleep Quality Index (PSQI), and Quality of Life in Epilepsy-31 (QOLIE-31) were used to evaluate comorbidities and quality of life. Statistical analysis was performed using SPSS\u00a026.0. The major clinical measurements were changes in the scales above before and after VNS implantation during follow-up. Generalized estimation model was applied to illustrate the effect over time an its relation to seizure control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 113 participants met the inclusion criteria. Baseline characteristics were comparable between the\u00a0comorbidity and non-comorbidity groups in terms of gender, seizure onset, age at VNS implantation, seizure types, or the number of antiseizure medications used. Significant improvements were observed from the implantation to the end of follow-up. The PSQI score decreased from 5.43\u2009\u00b1\u20093.60 to 4.44\u2009\u00b1\u20093.14 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01), indicating better sleep quality. Depressive symptoms (NDDI-E) and anxiety symptoms (GAD-7) decreased significantly, with scores dropping from 6.49\u2009\u00b1\u20094.67 to 4.83\u2009\u00b1\u20094.37 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01) and from 7.15\u2009\u00b1\u20095.06 to 4.95\u2009\u00b1\u20093.69 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01), respectively. The QOLIE-31 score increased from 54.40\u2009\u00b1\u200915.70 to 61.33\u2009\u00b1\u200916.19 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01), suggesting improved quality of life. Further analysis indicated that in the early second postoperative follow-up (1\u00a0month after implantation), the scales had already improved significantly (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001 for PSQI and QOLIE-31,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.006 for NDDI-E and GAD-7). We did not find any statistically significant difference between patients with comorbidity and those without on the efficacy of any scales in this study. The efficacy of VNS on the four scales above was related to follow-up time, with a\u00a0slightly rebound at the last two follow-ups. The NDDI-E as well as the GAD-7 scores were related to better seizure control according to the\u00a0GEE model. Higher stimulation currents over 1\u00a0mA did not improve the efficacy of VNS on the comorbid conditions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>VNS implantation significantly improved sleep quality, mental health, and overall quality of life in adult patients with epilepsy. Such effects could be observed shortly after the implantation and were mostly long-lasting. Further research is needed to validate its long-term effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42494-025-00222-6","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:35:31Z","timestamp":1748565331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dynamic changes in comorbid conditions following vagus nerve stimulation for epilepsy"],"prefix":"10.1186","volume":"7","author":[{"given":"Deng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7676-3288","authenticated-orcid":false,"given":"Xintong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"222_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.seizure.2020.09.027","volume":"83","author":"DH Toffa","year":"2020","unstructured":"Toffa DH, Touma L, El Meskine T, Bouthillier A, Nguyen DK. Learnings from 30 years of reported efficacy and safety of vagus nerve stimulation (VNS) for epilepsy treatment: A critical review. Seizure. 2020;83:104\u201323.","journal-title":"Seizure"},{"key":"222_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neubiorev.2021.04.018","volume":"127","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhan G, Cai Z, Jiao B, Zhao Y, Li S, Luo A. Vagus nerve stimulation in brain diseases: Therapeutic applications and biological mechanisms. Neurosci Biobehav Rev. 2021;127:37\u201353.","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"222_CR3","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1007\/s00415-022-10967-6","volume":"269","author":"S Batson","year":"2022","unstructured":"Batson S, Shankar R, Conry J, Boggs J, Radtke R, Mitchell S, et al. Efficacy and safety of VNS therapy or continued medication management for treatment of adults with drug-resistant epilepsy: systematic review and meta-analysis. J Neurol. 2022;269(6):2874\u201391.","journal-title":"J Neurol"},{"key":"222_CR4","doi-asserted-by":"publisher","unstructured":"Lyons P, Wheless J, Verner R, Ferreira J, Liow K, Valeriano J, et al. Vagus nerve stimulation in Lennox-Gastaut syndrome: Twenty-four-month data and experience from the CORE-VNS study. Epilepsia. 2025. https:\/\/doi.org\/10.1111\/epi.18289.","DOI":"10.1111\/epi.18289"},{"issue":"Suppl 4","key":"222_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/epi.12546","volume":"55","author":"EH Kossoff","year":"2014","unstructured":"Kossoff EH, Shields WD. Nonpharmacologic care for patients with Lennox-Gastaut syndrome: ketogenic diets and vagus nerve stimulation. Epilepsia. 2014;55(Suppl 4):29\u201333.","journal-title":"Epilepsia"},{"key":"222_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.seizure.2021.02.015","volume":"86","author":"SA Abdelmoity","year":"2021","unstructured":"Abdelmoity SA, Abdelmoity AA, Riordan SM, Kaufman C, Le Pichon JB, Abdelmoity A. The efficacy and tolerability of auto-stimulation-VNS in children with Lennox-Gastaut syndrome. Seizure. 2021;86:168\u201374.","journal-title":"Seizure"},{"issue":"3","key":"222_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/aor.14007","volume":"46","author":"NL Opie","year":"2022","unstructured":"Opie NL, O\u2019Brien TJ. The potential of closed-loop endovascular neurostimulation as a viable therapeutic approach for drug-resistant epilepsy: A critical review. Artif Organs. 2022;46(3):337\u201348.","journal-title":"Artif Organs"},{"issue":"3","key":"222_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s13311-014-0280-3","volume":"11","author":"FT Sun","year":"2014","unstructured":"Sun FT, Morrell MJ. Closed-loop neurostimulation: the clinical experience. Neurotherapeutics. 2014;11(3):553\u201363.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"222_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S1474-4422(15)00225-2","volume":"15","author":"MR Keezer","year":"2016","unstructured":"Keezer MR, Sisodiya SM, Sander JW. Comorbidities of epilepsy: current concepts and future perspectives. Lancet Neurol. 2016;15(1):106\u201315.","journal-title":"Lancet Neurol"},{"key":"222_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2020.106480","volume":"168","author":"LN Zhu","year":"2020","unstructured":"Zhu LN, Chen D, Deng Y, He J, He YJ, Zhou D, et al. Long-term seizure, comorbidity and socioeconomic outcomes of patients with convulsive epilepsy in rural West China. Epilepsy Res. 2020;168:106480.","journal-title":"Epilepsy Res"},{"issue":"8","key":"222_CR11","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.2174\/1570159X20666220627160048","volume":"21","author":"M Tallarico","year":"2023","unstructured":"Tallarico M, Pisano M, Leo A, Russo E, Citraro R, De Sarro G. Antidepressant Drugs for Seizures and Epilepsy: Where do we Stand? Curr Neuropharmacol. 2023;21(8):1691\u2013713.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"222_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/epi4.12100","volume":"3","author":"AY Chan","year":"2018","unstructured":"Chan AY, Rolston JD, Rao VR, Chang EF. Effect of neurostimulation on cognition and mood in refractory epilepsy. Epilepsia Open. 2018;3(1):18\u201329.","journal-title":"Epilepsia Open"},{"issue":"10","key":"222_CR13","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1111\/epi.17329","volume":"63","author":"HD Simpson","year":"2022","unstructured":"Simpson HD, Schulze-Bonhage A, Cascino GD, Fisher RS, Jobst BC, Sperling MR, et al. Practical considerations in epilepsy neurostimulation. Epilepsia. 2022;63(10):2445\u201360.","journal-title":"Epilepsia"},{"issue":"4","key":"222_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1212\/WNL.0000000000003532","volume":"88","author":"JP Szaflarski","year":"2017","unstructured":"Szaflarski JP, Gloss D, Binder JR, Gaillard WD, Golby AJ, Holland SK, et al. Practice guideline summary: Use of fMRI in the presurgical evaluation of patients with epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2017;88(4):395\u2013402.","journal-title":"Neurology"},{"issue":"4","key":"222_CR15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jchemneu.2010.12.002","volume":"42","author":"R Ruffoli","year":"2011","unstructured":"Ruffoli R, Giorgi FS, Pizzanelli C, Murri L, Paparelli A, Fornai F. The chemical neuroanatomy of vagus nerve stimulation. J Chem Neuroanat. 2011;42(4):288\u201396.","journal-title":"J Chem Neuroanat"},{"issue":"1","key":"222_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/epi.17811","volume":"65","author":"J Seth","year":"2024","unstructured":"Seth J, Couper RG, Burneo JG, Suller Marti A. Effects of vagus nerve stimulation on the quality of sleep and sleep apnea in patients with drug-resistant epilepsy: A systematic review. Epilepsia. 2024;65(1):73\u201383.","journal-title":"Epilepsia"},{"issue":"2\u20133","key":"222_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0920-1211(00)00181-9","volume":"42","author":"G Elger","year":"2000","unstructured":"Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res. 2000;42(2\u20133):203\u201310.","journal-title":"Epilepsy Res"},{"issue":"6","key":"222_CR18","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3171\/2011.7.JNS11977","volume":"115","author":"DJ Englot","year":"2011","unstructured":"Englot DJ, Chang EF, Auguste KI. Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response. J Neurosurg. 2011;115(6):1248\u201355.","journal-title":"J Neurosurg"},{"issue":"2","key":"222_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1006\/ebeh.2000.0046","volume":"1","author":"CL Harden","year":"2000","unstructured":"Harden CL, Pulver MC, Ravdin LD, Nikolov B, Halper JP, Labar DR. A Pilot Study of Mood in Epilepsy Patients Treated with Vagus Nerve Stimulation. Epilepsy Behav. 2000;1(2):93\u20139.","journal-title":"Epilepsy Behav"},{"issue":"1","key":"222_CR20","first-page":"53","volume":"14","author":"HA Sackeim","year":"2001","unstructured":"Sackeim HA, Keilp JG, Rush AJ, George MS, Marangell LB, Dormer JS, et al. The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14(1):53\u201362.","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"issue":"3","key":"222_CR21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.clinph.2003.10.026","volume":"115","author":"P Rizzo","year":"2004","unstructured":"Rizzo P, Beelke M, De Carli F, Canovaro P, Nobili L, Robert A, et al. Modifications of sleep EEG induced by chronic vagus nerve stimulation in patients affected by refractory epilepsy. Clin Neurophysiol. 2004;115(3):658\u201364.","journal-title":"Clin Neurophysiol"},{"issue":"Suppl 4","key":"222_CR22","doi-asserted-by":"publisher","first-page":"S255","DOI":"10.4103\/2152-7806.103015","volume":"3","author":"SE Krahl","year":"2012","unstructured":"Krahl SE, Clark KB. Vagus nerve stimulation for epilepsy: A review of central mechanisms. Surg Neurol Int. 2012;3(Suppl 4):S255-259.","journal-title":"Surg Neurol Int"},{"issue":"9","key":"222_CR23","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11910-022-01219-1","volume":"22","author":"AH Roliz","year":"2022","unstructured":"Roliz AH, Kothare S. The Interaction Between Sleep and Epilepsy. Curr Neurol Neurosci Rep. 2022;22(9):551\u201363.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"222_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/01.wnp.0000206877.90232.cb","volume":"23","author":"N Foldvary-Schaefer","year":"2006","unstructured":"Foldvary-Schaefer N, Grigg-Damberger M. Sleep and epilepsy: what we know, don\u2019t know, and need to know. J Clin Neurophysiol. 2006;23(1):4\u201320.","journal-title":"J Clin Neurophysiol"},{"issue":"3","key":"222_CR25","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1017\/S0317167100002638","volume":"30","author":"L Nagarajan","year":"2003","unstructured":"Nagarajan L, Walsh P, Gregory P, Stick S, Maul J, Ghosh S. Respiratory pattern changes in sleep in children on vagal nerve stimulation for refractory epilepsy. Can J Neurol Sci. 2003;30(3):224\u20137.","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"222_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.brainres.2006.08.048","volume":"1119","author":"RW Roosevelt","year":"2006","unstructured":"Roosevelt RW, Smith DC, Clough RW, Jensen RA, Browning RA. Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat. Brain Res. 2006;1119(1):124\u201332.","journal-title":"Brain Res"},{"issue":"8","key":"222_CR27","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1528-1157.1999.tb00818.x","volume":"40","author":"BR Walker","year":"1999","unstructured":"Walker BR, Easton A, Gale K. Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius. Epilepsia. 1999;40(8):1051\u20137.","journal-title":"Epilepsia"},{"issue":"1","key":"222_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0920-1211(95)00035-9","volume":"22","author":"DK Naritoku","year":"1995","unstructured":"Naritoku DK, Terry WJ, Helfert RH. Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve. Epilepsy Res. 1995;22(1):53\u201362.","journal-title":"Epilepsy Res"},{"issue":"4","key":"222_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0006-3223(99)00308-X","volume":"47","author":"MS George","year":"2000","unstructured":"George MS, Sackeim HA, Rush AJ, Marangell LB, Nahas Z, Husain MM, et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry. 2000;47(4):287\u201395.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"222_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.neubiorev.2005.01.004","volume":"29","author":"DA Groves","year":"2005","unstructured":"Groves DA, Brown VJ. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci Biobehav Rev. 2005;29(3):493\u2013500.","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"222_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0006-3223(99)00304-2","volume":"47","author":"AJ Rush","year":"2000","unstructured":"Rush AJ, George MS, Sackeim HA, Marangell LB, Husain MM, Giller C, et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry. 2000;47(4):276\u201386.","journal-title":"Biol Psychiatry"},{"key":"222_CR32","doi-asserted-by":"crossref","unstructured":"Hamid H, Liu H, Cong X, Devinsky O, Berg AT, Vickrey BG, et al. Long-term association between seizure outcome and depression after resective epilepsy surgery. Neurology. 2011;77(22):1972\u20136.","DOI":"10.1212\/WNL.0b013e31823a0c90"}],"container-title":["Acta Epileptologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42494-025-00222-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42494-025-00222-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42494-025-00222-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:35:33Z","timestamp":1748565333000},"score":1,"resource":{"primary":{"URL":"https:\/\/aepi.biomedcentral.com\/articles\/10.1186\/s42494-025-00222-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["222"],"URL":"https:\/\/doi.org\/10.1186\/s42494-025-00222-6","relation":{},"ISSN":["2096-9384","2524-4434"],"issn-type":[{"value":"2096-9384","type":"print"},{"value":"2524-4434","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of West China Hospital, Sichuan University\u00a0(2022[1847]).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Author Dong Zhou is the member of the Editorial Board for\n                      Acta Epileptologica\n                      , who was not involved in the journal\u2019s review of or decisions related to this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}